Literature DB >> 10783943

Surgical treatment for severe diabetic macular edema with massive hard exudates.

C M Yang1.   

Abstract

PURPOSE: Massive diabetic macular exudates respond poorly to conventional laser treatment. The purpose of this study was to analyze the surgical results of eyes with massive hard exudates secondary to diabetic macular edema treated with combined pars plana vitrectomy, posterior hyaloid removal, focal endolaser treatment, and panretinal photocoagulation.
METHODS: The author retrospectively analyzed the surgical outcome of 13 consecutive eyes (11 patients) with massive diabetic macular exudates. All patients had had at least one session of focal and/or grid laser treatment without any effect. Pars plana vitrectomy, posterior hyaloid removal, focal macular endolaser treatment, and intraoperative panretinal photocoagulation were performed. Postoperative visual acuity, evolution of macular edema, and hard exudates were recorded.
RESULTS: All 13 eyes showed significant decreases in macular edema and hard exudates, a process that became clinically obvious 3 months after the operation. Eleven eyes had improved vision of at least two lines during an average follow-up period of 14.8 months. Intraoperative and postoperative complications included angle closure glaucoma (one eye), persistent vitreous hemorrhage (two eyes), choroidal detachment (one eye), intravitreal fibrin formation (one eye), epiretinal membrane formation (one eye), and neovascular glaucoma (one eye).
CONCLUSION: Combined surgery may offer an opportunity for improvement of vision and reduction of massive macular exudates in patients with severe diabetic macular edema.

Entities:  

Mesh:

Year:  2000        PMID: 10783943

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  8 in total

Review 1.  [Surgery for macular edema].

Authors:  C Haritoglou; A Kampik
Journal:  Ophthalmologe       Date:  2004-06       Impact factor: 1.059

2.  Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction.

Authors:  Julia A Haller; Haijing Qin; Rajendra S Apte; Roy R Beck; Neil M Bressler; David J Browning; Ronald P Danis; Adam R Glassman; Joseph M Googe; Craig Kollman; Andreas K Lauer; Mark A Peters; Margaret E Stockman
Journal:  Ophthalmology       Date:  2010-03-17       Impact factor: 12.079

3.  Prediction of postoperative visual outcome after pars plana vitrectomy based on preoperative multifocal electroretinography in eyes with diabetic macular edema.

Authors:  Yong Min Kim; Soo Young Lee; Hyoung Jun Koh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-05-06       Impact factor: 3.117

4.  Intravitreal triamcinolone injection for chronic diabetic macular oedema with severe hard exudates.

Authors:  Remzi Avci; Berkant Kaderli
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-07-21       Impact factor: 3.117

5.  Aqueous Humor Cytokine Levels in Diabetic Macular Edema Patients with Cotton-Wool Spots.

Authors:  Young-Gun Park; Donghyun Jee; Jin-Woo Kwon
Journal:  J Diabetes Res       Date:  2019-12-21       Impact factor: 4.011

6.  Vitrectomy with internal limiting membrane peeling versus nonsurgical treatment for diabetic macular edema with massive hard exudates.

Authors:  Hsuan-Chieh Lin; Chung-May Yang; San-Ni Chen; Yi-Ting Hsieh
Journal:  PLoS One       Date:  2020-07-31       Impact factor: 3.240

Review 7.  Diabetic macular edema: Evidence-based management.

Authors:  David J Browning; Michael W Stewart; Chong Lee
Journal:  Indian J Ophthalmol       Date:  2018-12       Impact factor: 1.848

8.  Macular edema resolution assessment with implantable dexamethasone in diabetic retinopathy (MERIT): a pilot study.

Authors:  Jay Chhablani; Mahima Jhingan; Abhilash Goud; Kiran Kumar Vupparaboina; Taraprasad Das
Journal:  Clin Ophthalmol       Date:  2018-07-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.